Real World Evidence Shows Johnson & Johnson COVID-19 Vaccine Demonstrates Durable Protection Against Breakthrough Infection, Hospitalization, And Intensive Care Unit Admission In The United States
January 6, 2022
Published by The Street By PR Newswire NEW BRUNSWICK, N.J., Jan. 6, 2022 /PRNewswire/ — Johnson & Johnson (JNJ) – Get Johnson & Johnson Report